Antinephrin Autoantibodies: Biomarker for Kidney Disease?

  • 📰 Medscape
  • ⏱ Reading Time:
  • 61 sec. here
  • 22 min. at publisher
  • 📊 Quality Score:
  • News: 94%
  • Publisher: 55%

Chronic Renal Failure News

Chronic Kidney Failure,CKD - Chronic Kidney Disease,Chronic Kidney Disease

Using an innovative analysis technique, researchers identified antinephrin autoantibodies as markers of difficult to diagnose kidney diseases.

STOCKHOLM — People with difficult to diagnose kidney disease s linked to nephrotic syndrome show uniquely high levels of antinephrin autoantibodies, suggesting a novel biomarker and breakthrough development in diagnosing and managing the diseases.

For the trial, they enrolled 357 patients in the United States and Europe with MCD and FSGS, as well as other glomerular diseases, including -naive patients with active MCD and idiopathic nephrotic syndrome, the prevalence of antinephrin autoantibodies was as high as 69% and 90%, respectively. To further investigate the potential effects of nephrin immunization, the authors conducted studies on mice models that mimicked MCD, and importantly, they found that single nephrin immunization led toAlthough previous studies have suggested the presence of antinephrin autoantibodies,"the difficulty has been in the detection," co-author Tobias B. Huber, MD, also of the University Medical Center Hamburg-Eppendorf, explained while presenting the study.

"Such antibody quantification can potentially transform the management of nephrotic syndromes by providing noninvasive alternatives for diagnosis, enhancing treatment evaluation, and improving kidney-transplantation strategies in patients with recurrent primary FSGS," the authors explain. , Ivan Rychlik, MD, PhD, Department of Medicine, Charles University, Prague, Czech Republic, said the study has important implications.

Source: Healthcare Press (healthcarepress.net)

Chronic Kidney Failure CKD - Chronic Kidney Disease Chronic Kidney Disease CKD Renal Failure Renal Insufficiency Kidney Insufficiency Kidney Failure Renal Impairment Renal Disease Kidney Disease Kidney Disorder Renal Disorder Nephropathy End Stage Renal Disease ESRD - End Stage Renal Disease ESRD ESKD End-Stage Kidney Disease (ESKD)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Newly identified PET biomarker predicts success of immune checkpoint blockade therapyThe protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.
Source: ScienceDaily - 🏆 452. / 53 Read more »

Scientists Discover Earliest-Yet Alzheimer’s BiomarkerScience, Space and Technology News 2024
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

Biomarker found to help identify cells that can repair damaged blood vesselsResearchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels.
Source: ScienceDaily - 🏆 452. / 53 Read more »

Semaglutide Kidney Benefits Extend to Those Without DiabetesThe effects in an obese population without diabetes and low rates of kidney disease suggest a 'potential role in the primary prevention of CKD.'
Source: Medscape - 🏆 386. / 55 Read more »

Biden-Harris Administration Acts to Improve Access to Kidney TransplantsProposed model would break down silos of care in kidney transplant process
Source: HHSGov - 🏆 147. / 63 Read more »

Can a Risk Score Predict Kidney Injury After Cisplatin?Cisplatin is lifesaving for many people with cancer, but acute kidney injury is a common and serious toxicity — can a tool identify those at risk?
Source: Medscape - 🏆 386. / 55 Read more »